The Switch: Bowing again to the FDA, 23andMe stops issuing health-related genetic reports

The Google-backed genetics company 23andMe will no longer be providing personalized health analyses to consumers based on their DNA samples in an effort to comply with a federal safety warning. When the Food and Drug Administration expressed concern about the product late last month, 23andMe responded this week by halting its advertising for the kit. In a statement Thursday night, the firm went a step further, announcing that it would only provide ancestry information and raw health data. A spok...